🚀 Ready to bring your medical device to India?
The right regulatory strategy can mean the difference between a smooth market entry and costly delays.
Follow us for practical guidance, regulatory updates, and insights that help you move forward with confidence.
Recurrence is a quiet quality failure. Close a CAPA today, only to see the same issue return tomorrow.
RegXtrakt helps prevent recurrence with:
🔄 Linked CAPA & root causes
🤖 Recurrence risk prediction
📈 Risk-based prioritisation
Close the loop. Keep it closed.
Every auditor asks for the ISO 14971 risk file.
The question is: can you trace every hazard to the evidence?
Risk management protects patients. Traceability proves it.
#ISO14971#MedTech#Quality
ISO 13485 ≠ Fifth Schedule compliance.
For India’s Class A & B device manufacturers, MD-5 audits are against the Fifth Schedule of MDR 2017.
RegXtrakt maps every clause, shows live compliance gaps, and helps your team stay audit-
#MDR2017#ISO13485#MedicalDevices#Quality
India’s MedTech infrastructure is scaling fast. 🇮🇳
₹3,420 Cr PLI + new Medical Device Parks = more manufacturing.
But more production also means more audits, licences, and compliance.
Scale your QMS as fast as your factory.
#MedTech#MakeInIndia#PLI#QMS#CDSCO
India’s MedTech story in 3 numbers:
📈 +88% export growth (FY19–FY25)
🏭 10% → 30% domestic production share
🎯 US$20B export potential by FY30
The opportunity is global. Compliance will decide who wins.
#MedTech#MedicalDevices#MakeInIndia
A licence isn’t the finish line. It’s a living obligation.
Renewals. Post-approval changes. Periodic compliance. Miss one deadline, and the cost can be far greater than a reminder.
Stay audit-ready. Stay ahead.
#CDSCO#MedicalDevices#RegulatoryAffairs#MedTech
“What class is your device?” is where every regulatory pathway begins.
With CDSCO tightening classification requirements, getting it right has never been more important.
Know your class before you file.
#CDSCO#MedTech#RegulatoryAffairs#Compliance
One suite. Five modules. Every medical device obligation in one place.
Meet RegXtrakt for Medical Devices.
Built for CDSCO & MDR 2017—not adapted from pharma.
Regulatory. Quality. Safety. Labelling. Security.
One platform. Complete compliance.
#RegXtrakt#MedTech#RegTech
India's MedTech market didn't grow from ~400 to 4,000+ manufacturers despite regulation—it grew because of it.
With strict CDSCO risk pathways (Class A–D) now standard, regulatory compliance is no longer a hurdle. It’s core infrastructure.
#MedTech#CDSCO#Healthcare
A safety signal isn't just a PV problem. It's a labelling change, a variation, sometimes a market action.
RegXtrakt Safety lives on the same core as Regulatory — a signal lands in the same record your renewals are built from.
#Pharmacovigilance#DrugSafety#RegTech
10 years strong.
AKT Health is honored to partner with the Medical Device Regulatory and Quality Summit 2026 as Silver Partner.
Catch us in New Delhi this August.
#AKTHealth#MedDeviceCompliance
A safety signal isn't just a PV problem. It's a labelling change, a variation, sometimes a market action.
RegXtrakt Safety lives on the same core as Regulatory — a signal lands in the same record your renewals are built from.
#Pharmacovigilance#DrugSafety#RegTech
AKT Health is participating as a Silver Partner at the 10th Annual Medical Device Regulatory & Quality Summit 2026!
📅 18–19 August 2026
📍 Pride Plaza Hotel, Aerocity, New Delhi.
See you in New Delhi! 🇮🇳
#MedicalDevice#RegulatoryAffairs#DigitalHealth#AKTHealth
Your QMS and your regulatory system disagree about a product.
Which one is right?
Wrong question. There should only be ONE record.
In RegXtrakt, Quality runs on the same core as Regulatory — one product, one truth.
#QualityManagement#RegTech#Pharma